Biogen Inc.

Biogen Inc. is an American multinational biotechnology company that develops innovative therapies for neurological diseases and related conditions. Based in Cambridge, Massachusetts, Biogen's primary focus includes treatment options for disorders such as multiple sclerosis, Alzheimer's disease, and spinal muscular atrophy. The company is renowned for its involvement in research-driven initiatives that aim to address medical challenges and improve patient outcomes. Its significant contributions to neuroscience and its pipeline of potential new therapies keep it at the forefront of the biotech industry. Through partnerships with the scientific community and consistent research, Biogen continues to play a crucial role in advancing medical treatments and addressing unmet medical needs globally.